Instead, it is conceivable that the increase in CSF Cbl levels may be due to either the only partial recruitment of Cbl into MS CNS cells, or to abnormalities in the blood–brain and/or blood–SC barriers in MS [358]. This evidence concerns the gene CBL and myeloid sarcoma.